# A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer

> **NCT00584012** · PHASE1 · TERMINATED · sponsor: **Susan L Roeder** · enrollment: 9 (actual)

## Conditions studied

- Any Cancer
- Breast Cancer

## Interventions

- **DRUG:** Lovastatin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00584012
- **Lead sponsor:** Susan L Roeder
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Funding issues
- **Last updated:** 2018-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584012, "A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00584012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*